Reimbursement and Payment Methodologies

CMS is accepting comments until November 29 on a proposal to collect acquisition cost data from hospitals participating in the 340B drug discount program.

A federal judge rejected CMS’ motion to reconsider or issue a stay on her September order to vacate cuts to reimbursement to grandfathered off-campus provider-based departments.

CMS’ proposal mandating the disclosure of negotiated charges between hospitals and payers may exceed the agency’s legal authority and would have limited benefit to patients, according to the AHA.

Find your inspiration to stay informed and motived on your revenue integrity journey.

Take an in-depth look at the 2020 IPPS final rule to ensure your organization is ready for a major revision to the hospital wage index calculation and more.

Understand how new payment policies can help ease adoption of new technology.

Learn about the major proposed changes, including far-reaching and complex price transparency requirements.

Take a look at how court rulings have affected CMS' approach to 340B drug program reimbursement.

Consider the potential impact of CMS' prior authorization proposals.

Learn how defining the hospital chargemaster and billing plays into CMS' price transparency proposals.